Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00DXB
|
|||
| Former ID |
DNC007921
|
|||
| Drug Name |
3-mercapto-2-(piperidin-3-yl)propanoic acid
|
|||
| Synonyms |
CHEMBL245591; 3-mercapto-2-(piperidin-3-yl)propanoic acid; SCHEMBL2354438
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H15NO2S
|
|||
| Canonical SMILES |
C1CC(CNC1)C(CS)C(=O)O
|
|||
| InChI |
1S/C8H15NO2S/c10-8(11)7(5-12)6-2-1-3-9-4-6/h6-7,9,12H,1-5H2,(H,10,11)
|
|||
| InChIKey |
ZEKJYPSRDZCIDP-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Carboxypeptidase B2 (CPB2) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Complement and coagulation cascades | |||
| Pancreatic secretion | ||||
| Protein digestion and absorption | ||||
| Panther Pathway | Plasminogen activating cascade | |||
| Reactome | Metabolism of Angiotensinogen to Angiotensins | |||
| WikiPathways | Complement and Coagulation Cascades | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa). Bioorg Med Chem Lett. 2007 Mar 1;17(5):1349-54. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.